Simon Trowell

Oversight Committee Chair, TransCelerate; Vice President, Clinical Development Quality & Risk Management, GSK


A Medicinal and Pharmaceutical Chemist by training, Simon joined GSK in 1994 and has worked in a variety of clinical development, learning and development and quality risk management roles within Pharmaceutical R&D.

Simon leads the Quality & Risk Management function in Pharmaceutical R&D that oversees the Trial Master File strategy and process; manages the approach to written standards for clinical development; ensures alignment of clinical development ways of working with current and emergent regulations; and, ensures a fit for purpose approach to quality culture and risk management. In addition to these functional accountabilities, Simon is the Risk Owner for the GSK enterprise risk of Research Practices and serves as GSK’s representative on, and the Chairperson of, the TransCelerate Clinical Oversight Committee.